Research led by Naval Medical University's Changzheng Hospital in China reports that an off-the-shelf cell therapy built from induced pluripotent stem cells (iPSCs) loosened life-limiting skin and ...
In the study, "An iPSC-derived CD19/BCMA CAR-NK therapy in a patient with systemic sclerosis," published in Cell, researchers engineered an allogeneic cell therapy, QN-139b, to deplete pathogenic B ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results